View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. Comment
February 16, 2018

Who were the top players in cardiovascular disease in 2017?

The total revenue from branded cardiovascular drugs in 2017 is projected to be just over $40 billion. Top companies in this space are putting a heavy focus on the anti-thrombotic segment, as these drugs continue to bring in the biggest profit and dominate the cardiovascular market.

By GlobalData Healthcare

The total revenue from branded cardiovascular drugs in 2017 is projected to be just over $40 billion. Top companies in this space are putting a heavy focus on the anti-thrombotic segment, as these drugs continue to bring in the biggest profit and dominate the cardiovascular market.

Figures ($M) represent projected 2017 global sales of cardiovascular products. Credit: GlobalData.

Bayer currently holds the top spot in the market with 2017 sales of $5.4 billion; however, Sanofi and BMS come in a close second and third with sales of $5.1 and $4.7 billion, respectively.

Overall, apart from the anticoagulants segment, companies are investing less frequently due to the heavily genericized and mature nature of the cardiovascular market. This and the high cost of drug development makes the cardiovascular market hard to penetrate, especially for smaller, less established companies.

The clear leaders in sales of cardiovascular drugs are Eliquis and Xarelto (NOACs). These two drugs currently represent over 30% of the total cardiovascular market and their shares will continue to expand.

Despite high clinical unmet needs, this market is not expected to grow significantly in the near future, with the exception of the NOACs class.

Figures ($M) represent projected 2017 global sales. Credit: GlobalData.

 

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU